HCW Biologics Inc. (HCWB) financial statements and ratios from SEC XBRL: revenue $54232.00 (TTM), net margin -14677.1%, revenue growth -97.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $54232.00 |
| Net Margin | -14677.1% |
| Revenue Growth (YoY) | -97.9% |
| EPS Growth (YoY) | 1280.5% |
| FCF Growth (YoY) | -7.6% |
| Price / Book | 0.42 |
| Price / Sales | 0.37 |
| FCF Yield | -831.6% |
| Altman Z-Score | -8.48 (distress) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.7 |
HCWB overview · HCWB earnings · HCWB KPIs · HCWB investor relations · HCWB ownership · HCWB peers · HCWB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.